BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

981 related articles for article (PubMed ID: 29278851)

  • 41. MiR-19a promotes epithelial-mesenchymal transition through PI3K/AKT pathway in gastric cancer.
    Lu WD; Zuo Y; Xu Z; Zhang M
    World J Gastroenterol; 2015 Apr; 21(15):4564-73. PubMed ID: 25914465
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Acacetin inhibits invasion, migration and TGF-β1-induced EMT of gastric cancer cells through the PI3K/Akt/Snail pathway.
    Zhang G; Li Z; Dong J; Zhou W; Zhang Z; Que Z; Zhu X; Xu Y; Cao N; Zhao A
    BMC Complement Med Ther; 2022 Jan; 22(1):10. PubMed ID: 35000605
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Elevated Expression of Zinc Finger Protein 703 Promotes Cell Proliferation and Metastasis through PI3K/AKT/GSK-3β Signalling in Oral Squamous Cell Carcinoma.
    Wang H; Deng X; Zhang J; Ou Z; Mai J; Ding S; Huo S
    Cell Physiol Biochem; 2017; 44(3):920-934. PubMed ID: 29176314
    [TBL] [Abstract][Full Text] [Related]  

  • 44. MiR-592 Promotes Gastric Cancer Proliferation, Migration, and Invasion Through the PI3K/AKT and MAPK/ERK Signaling Pathways by Targeting Spry2.
    He Y; Ge Y; Jiang M; Zhou J; Luo D; Fan H; Shi L; Lin L; Yang L
    Cell Physiol Biochem; 2018; 47(4):1465-1481. PubMed ID: 29949784
    [TBL] [Abstract][Full Text] [Related]  

  • 45. CDX2 inhibits invasion and migration of gastric cancer cells by phosphatase and tensin homologue deleted from chromosome 10/Akt signaling pathway.
    Liu YQ; Bai ZG; Ma XM; Zhang ZT
    Chin Med J (Engl); 2015 Apr; 128(8):1065-71. PubMed ID: 25881601
    [TBL] [Abstract][Full Text] [Related]  

  • 46. WSTF promotes proliferation and invasion of lung cancer cells by inducing EMT via PI3K/Akt and IL-6/STAT3 signaling pathways.
    Meng J; Zhang XT; Liu XL; Fan L; Li C; Sun Y; Liang XH; Wang JB; Mei QB; Zhang F; Zhang T
    Cell Signal; 2016 Nov; 28(11):1673-82. PubMed ID: 27449264
    [TBL] [Abstract][Full Text] [Related]  

  • 47. MicroRNA-936 promotes proliferation and invasion of gastric cancer cells by down-regulating FGF2 expression and activating P13K/Akt signaling pathway.
    Chen ZF; Wang J; Yu Y; Wei W
    Eur Rev Med Pharmacol Sci; 2020 Jun; 24(12):6707-6715. PubMed ID: 32633361
    [TBL] [Abstract][Full Text] [Related]  

  • 48. JARID2 promotes invasion and metastasis of hepatocellular carcinoma by facilitating epithelial-mesenchymal transition through PTEN/AKT signaling.
    Lei X; Xu JF; Chang RM; Fang F; Zuo CH; Yang LY
    Oncotarget; 2016 Jun; 7(26):40266-40284. PubMed ID: 27259236
    [TBL] [Abstract][Full Text] [Related]  

  • 49. miR-205-5p regulates epithelial-mesenchymal transition by targeting PTEN via PI3K/AKT signaling pathway in cisplatin-resistant nasopharyngeal carcinoma cells.
    Zhang P; Lu X; Shi Z; Li X; Zhang Y; Zhao S; Liu H
    Gene; 2019 Aug; 710():103-113. PubMed ID: 31158447
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Upregulation of Neural Precursor Cell Expressed Developmentally Downregulated 4-1 is Associated with Poor Prognosis and Chemoresistance in Lung Adenocarcinoma.
    Song YH; Zhang CQ; Chen FF; Lin XY
    Chin Med J (Engl); 2018 Jan; 131(1):16-24. PubMed ID: 29271375
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Transforming growth factor-β1-induced epithelial-mesenchymal transition in human esophageal squamous cell carcinoma via the PTEN/PI3K signaling pathway.
    Zhang HY; Wang ZQ; Li YY; Wang F; Zeng QR; Gao Y; Xuan XY; Li SS
    Oncol Rep; 2014 Nov; 32(5):2134-42. PubMed ID: 25175594
    [TBL] [Abstract][Full Text] [Related]  

  • 52. miR-29b regulates Ang II-induced EMT of rat renal tubular epithelial cells via targeting PI3K/AKT signaling pathway.
    Hu H; Hu S; Xu S; Gao Y; Zeng F; Shui H
    Int J Mol Med; 2018 Jul; 42(1):453-460. PubMed ID: 29568897
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Rosmarinic acid exerts an anticancer effect on osteosarcoma cells by inhibiting DJ-1 via regulation of the PTEN-PI3K-Akt signaling pathway.
    Ma Z; Yang J; Yang Y; Wang X; Chen G; Shi A; Lu Y; Jia S; Kang X; Lu L
    Phytomedicine; 2020 Mar; 68():153186. PubMed ID: 32088353
    [TBL] [Abstract][Full Text] [Related]  

  • 54. NETO2 promotes invasion and metastasis of gastric cancer cells via activation of PI3K/Akt/NF-κB/Snail axis and predicts outcome of the patients.
    Liu JY; Jiang L; He T; Liu JJ; Fan JY; Xu XH; Tang B; Shi Y; Zhao YL; Qian F; Wang Y; Cui YH; Yu PW
    Cell Death Dis; 2019 Feb; 10(3):162. PubMed ID: 30770791
    [TBL] [Abstract][Full Text] [Related]  

  • 55. LINC00511 promotes gastric cancer progression by regulating SOX4 and epigenetically repressing PTEN to activate PI3K/AKT pathway.
    Wang Q; Mao X; Luo F; Wang J
    J Cell Mol Med; 2021 Oct; 25(19):9112-9127. PubMed ID: 34427967
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Upregulated hsa_circRNA_100269 inhibits the growth and metastasis of gastric cancer through inactivating PI3K/Akt axis.
    Wang Z; Liu C
    PLoS One; 2021; 16(4):e0250603. PubMed ID: 33901239
    [TBL] [Abstract][Full Text] [Related]  

  • 57. MiR-19a promotes epithelial-mesenchymal transition through PI3K/AKT pathway in gastric cancer.
    Lu W; Xu Z; Zhang M; Zuo Y
    Int J Clin Exp Pathol; 2014; 7(10):7286-96. PubMed ID: 25400827
    [TBL] [Abstract][Full Text] [Related]  

  • 58. CXCL10/CXCR3 axis promotes the invasion of gastric cancer via PI3K/AKT pathway-dependent MMPs production.
    Zhou H; Wu J; Wang T; Zhang X; Liu D
    Biomed Pharmacother; 2016 Aug; 82():479-88. PubMed ID: 27470388
    [TBL] [Abstract][Full Text] [Related]  

  • 59. c-Src activation promotes nasopharyngeal carcinoma metastasis by inducing the epithelial-mesenchymal transition via PI3K/Akt signaling pathway: a new and promising target for NPC.
    Ke L; Xiang Y; Guo X; Lu J; Xia W; Yu Y; Peng Y; Wang L; Wang G; Ye Y; Yang J; Liang H; Kang T; Lv X
    Oncotarget; 2016 May; 7(19):28340-55. PubMed ID: 27078847
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Knockdown of TMPRSS3 inhibits gastric cancer cell proliferation, invasion and EMT via regulation of the ERK1/2 and PI3K/Akt pathways.
    Li SL; Chen X; Wu T; Zhang XW; Li H; Zhang Y; Ji ZZ
    Biomed Pharmacother; 2018 Nov; 107():841-848. PubMed ID: 30142546
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 50.